A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy

Amirhossein Bahreyni(St. Paul's Co-educational College), Honglin Luo(University of British Columbia)
BMC Medicine
May 24, 2023
Cited by 20


Related Papers